4th iPSC Drug Development and Manufacturing Summit
Evvnt Promotion / evvnt
Archivo
01.10.2024 - 03.10.2024 The Colonnade Hotel, 120 Huntington Avenue, 02116 Boston, Massachusetts, USA
Time: 08:00 - 17:00
Temas de la conferencia
With Kenai Therapeutics emerging from stealth with an $82 Million Series A funding round, 2024 has started strong for iPSC drug developers looking to showcase the potential of their pipelines ahead of the next wave of investment.
With Kenai Therapeutics emerging from stealth with an $82 Million Series A funding round, 2024 has started strong for iPSC drug developers looking to showcase the potential of their pipelines ahead of the next wave of investment.
Organizador profesional (PCO)
Hanson Wade
Hanson Wade
Observaciones
Brochure: https://go.evvnt.com/2453698-3?pid=4832
Speakers: Allen Feng, Founder & Chief Scientific Officer, HebeCell, Anne Plant, Fellow Chief, Biosystems and Biomaterials Division, National Institute of Standards & Technology (NIST), and more
Brochure: https://go.evvnt.com/2453698-3?pid=4832
Speakers: Allen Feng, Founder & Chief Scientific Officer, HebeCell, Anne Plant, Fellow Chief, Biosystems and Biomaterials Division, National Institute of Standards & Technology (NIST), and more
Información e inscripción:
https://go.evvnt.com/2453698-2?pid=4832
Ms. Lara Chick
Medicina General
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."
